Why Publish Your Research With Carcinogenesis?

Carcinogenesis: Integrative Cancer Research is a multi-disciplinary journal that brings together all the varied aspects of research that will ultimately lead to the prevention of cancer in humans.

As of 2024, Carcinogenesis has expanded its scope to provide a quality and trusted home for a wider range of your research. Research categories now include Cancer Prevention, Epidemiology, and Molecular Epidemiology; Inflammation, Tumor Microenvironment and Cancer Immunology; Carcinogenesis, Genetics and Epigenetics; and Translational Cancer Research.

Reputation

• Carcinogenesis has an Impact Factor of 3.3 (2023) and a CiteScore of 8.4.
• Carcinogenesis reaches a global audience of leading specialists, which means your article will be read, used, cited, and built upon by your colleagues in the field.
• Carcinogenesis continuously publishes innovative research and has a High Impact Research collection, featuring a selection of excellent articles published in the journal.

Editorial Support

• The Editors take great pride in providing an efficient but rigorous review process to our journal authors, so you can be confident that your work will be published at its best.
• Carcinogenesis has an experienced, geographically diverse Editorial Board who support the international reach of your work with their extensive networks in the cancer research field.

Easy Submissions Process

• Submit your paper with ease using ScholarOne Manuscripts.
• Our Instructions to Authors page explains each step of the submissions process, including how to prepare and what to expect.
• A fast track submission route is available for a very limited number of exceptional papers each year. To learn more about the process, and how you can apply for fast track submission, head to the information page here.

Discoverability

• Carcinogenesis is indexed in various key repositories, including PUBMED, BIOBASE, and BIOSIS Previews, supporting the rapid and global dissemination of your work.

Optional Open Access

• Carcinogenesis offers the option of publishing under either a standard licence or an open access licence. Some funders require open access publication as a condition of funding.
• OUP has a growing number of Read and Publish agreements with institutions and consortia which provide funding for open access publishing. This means authors from participating institutions can publish open access, and the institution may pay the charge. Find out if your institution is participating here.
• Want to learn more about Open Access? Head to this page.

Wide-ranging scope and policy

• To explore the newly expanded scope of Carcinogensis, visit our Author Guidelines here.
• Advance access publishing means your content will be available online as soon as possible. Once a paper is accepted, the pre-proofed, pre-copyedited accepted manuscript will be published online soon after.

Published by an Academic Publisher

• As a department of the University of Oxford, Oxford University Press (OUP) is a mission-driven, non-profit publisher committed to delivering world-class academic and educational resources and making them available as widely as possible.
• OUP understands the importance of making research accessible so that not only researchers, but also practitioners and policymakers around the world, are well-equipped with the latest information to better serve their communities.
• Oxford University Press has a resource center to answer all of your questions before, during, and after publication—including advice on how best to promote your work once published.

Ready to submit your article to Carcinogenesis?

Here are the next steps you can take towards publishing with Carcinogenesis:

• Review the Instructions to Authors for information on journal policies and manuscript preparation
• Log into Carcinogenesis’ submission site
• Sign up to email alerts to stay up to date on the latest articles and journal initiatives

Any questions about submitting to the journal? Email the team at: [email protected]